Institute for Precision Cardiovascular Medicine
The AHA Institute for Precision Cardiovascular Medicine created a new model for bringing together science and technology to drive breakthroughs in cardiovascular and brain health and disease.
The American Heart Association (AHA) Institute for Precision Cardiovascular Medicine (Institute) is at the forefront of the application of data science and technology to the fields of cardiovascular and brain disease and well-being.
We fund and train the next generation of medical researchers who will need skills and experience in data science, cloud-computing, and artificial intelligence to solve the challenges we face today.
We've built the AHA Precision Medicine Platform, a secure, cloud-based data analytics platform specifically for data scientists in the medical research field to facilitate global collaboration among scientists around the world and to advance scientific breakthroughs.
We've launched a lifetime study, My Research Legacy, to understand cardiovascular and brain health and wellness with diverse communities and experts.
We've exploring how coronary heart disease develops and how we can stop its progression to heart attacks and strokes in radical new ways through One Brave Idea.
We've leveraging super computers through a collaboration with Lawrence Livermore National Labs to predict how drugs bind to their target proteins and are testing how these predictions in experimental environments can identify new drugs and targeted therapies in a fraction of the time it usually takes.
But the Institute's work doesn't end there. We're working with experts, empowering individuals, more fully equipping researchers, training problem solvers, fueling and funding scientific discoveries, and translating science for clinicians and patients.
Since 2014, we’ve funded more than 65 grants totaling more than $18 million.
The AHA Precision Medicine Platform offers cloud-computing, diverse datasets, data harmonization, and secure workspaces equipped with state of the art analytics tools, such as artificial intelligence, to researchers around the globe.
My Research Legacy is building a diverse community of more than 250,000 to learn how things like their daily lifestyle choices and genetic makeup can impact hearts and brains.
Through a $75 million investment in a diverse team of scientists, One Brave Idea has set out to find the weapons and strategies to win the fight against coronary heart disease.
Grantees have published more than 200 papers in scientific journals.
The Center for Accelerated Drug Discovery is leveraging the power of supercomputing to reduce the time to market for new drugs and therapies by up to 50 percent.
Meet our strategic collaborators
Advancing the science of precision medicine together.